Linking Induction and Transrepression of PPARβ/δ with Cellular Function

References (57)

1. 1 The Phosphoinositide 3-Kinase Pathway [DOI]
2. 2 Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators [DOI]
3. 3 Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ [DOI]
4. 4 The Journal of Investigative Dermatology [DOI]
5. 5 Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1 [DOI]
6. 6 Interleukin‐6 is the major regulator of acute phase protein synthesis in adult human hepatocytes [DOI]
7. 7 Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ [DOI]
8. 8 PPARδ regulates glucose metabolism and insulin sensitivity [DOI]
9. 9 Polarity and Specific Sequence Requirements of Peroxisome Proliferator-activated Receptor (PPAR)/Retinoid X Receptor Heterodimer Binding to DNA [DOI]
10. 10 PPARγ3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoter [DOI]
11. 11 Antiapoptotic Role of PPARβ in Keratinocytes via Transcriptional Control of the Akt1 Signaling Pathway [DOI]
12. 12 Role of glycogen synthase kinase-3 in TNF-α-induced NF-κB activation and apoptosis in hepatocytes [DOI]
13. 13 PPARδ-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis [DOI]
14. 14 Maps and legends: The quest for dissociated ligands of the glucocorticoid receptor [DOI]
15. 15 PPARs and the Cardiovascular System [DOI]
16. 16 PPARδ regulates multiple proinflammatory pathways to suppress atherosclerosis [DOI]
17. 17 Crosstalk between peroxisome proliferator-activated receptor δ and VEGF stimulates cancer progression [DOI]
18. 18 Activation of Peroxisome Proliferator–Activated Receptor β/δ Inhibits Lipopolysaccharide-Induced Cytokine Production in Adipocytes by Lowering Nuclear Factor-κB Activity via Extracellular Signal–Related Kinase 1/2 [DOI]
19. 19 Edible blue-green algae reduce the production of pro-inflammatory cytokines by inhibiting NF-κB pathway in macrophages and splenocytes [DOI]
20. 20 Nuclear Control of the Inflammatory Response in Mammals by Peroxisome Proliferator-Activated Receptors [DOI]
21. 21 Mechanism of Action of a Peroxisome Proliferator-Activated Receptor (PPAR)-δ Agonist on Lipoprotein Metabolism in Dyslipidemic Subjects with Central Obesity [DOI]
22. 22 Lipid Effects of Peroxisome Proliferator-Activated Receptor-Δ Agonist GW501516 in Subjects With Low High-Density Lipoprotein Cholesterol [DOI]
23. 23 The PPARδ-mediated inhibition of angiotensin II-induced premature senescence in human endothelial cells is SIRT1-dependent [DOI]
24. 24 Suppression of Pro-inflammatory Adhesion Molecules by PPAR-δ in Human Vascular Endothelial Cells [DOI]
25. 25 PPAR‐α and ‐γ but not ‐δ agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF‐κB‐independent effect [DOI]
26. 26 PPARδ Enhances Keratinocyte Proliferation in Psoriasis and Induces Heparin-Binding EGF-Like Growth Factor [DOI]
27. 27 Peroxisome Proliferator-activated Receptor β (δ)-dependent Regulation of Ubiquitin C Expression Contributes to Attenuation of Skin Carcinogenesis [DOI]
28. 28 The prognostic value of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13) deficiency in septic shock patients involves interleukin-6 and is not dependent on disseminated intravascular coagulation [DOI]
29. 29 Genomewide Analyses Define Different Modes of Transcriptional Regulation by Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) [DOI]
30. 30 Protective Role of Peroxisome Proliferator–activated Receptor-β/δ in Septic Shock [DOI]
31. 31 PPARδ agonist L-165041 inhibits rat vascular smooth muscle cell proliferation and migration via inhibition of cell cycle [DOI]
32. 32 Flavanol metabolites reduce monocyte adhesion to endothelial cells through modulation of expression of genes via p38‐MAPK and p65‐Nf‐kB pathways [DOI]
33. 33 The Nuclear Hormone Receptor Peroxisome Proliferator-Activated Receptor β/δ Potentiates Cell Chemotactism, Polarization, and Migration [DOI]
34. 34 TNF-α inhibits PPARβ/δ activity and SIRT1 expression through NF-κB in human adipocytes [DOI]
35. 35 Peroxisome Proliferator–Activated Receptor δ Agonist GW1516 Attenuates Diet-Induced Aortic Inflammation, Insulin Resistance, and Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice [DOI]
36. 36 Peroxisome Proliferator–Activated Receptor–β/δ, the Acute Signaling Factor in Prostacyclin-Induced Pulmonary Vasodilation [DOI]
37. 37 Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy [DOI]
38. 38 PPARδ inhibits IL-1β-stimulated proliferation and migration of vascular smooth muscle cells via up-regulation of IL-1Ra [DOI]
39. 39 The PPARβ/δAgonist GW0742 Relaxes Pulmonary Vessels and Limits Right Heart Hypertrophy in Rats with Hypoxia-Induced Pulmonary Hypertension [DOI]
40. 40 Analysis of the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) cistrome reveals novel co-regulatory role of ATF4 [DOI]
41. 41 Peroxisome Proliferator-activated Receptor δ Is Up-regulated during Vascular Lesion Formation and Promotes Post-confluent Cell Proliferation in Vascular Smooth Muscle Cells [DOI]
42. 42 Structural requirements and cell-type specificity for ligand activation of peroxisome proliferator-activated receptors [DOI]
43. 43 The PPARδ agonist GW501516 suppresses interleukin‐6‐mediated hepatocyte acute phase reaction via STAT3 inhibition [DOI]
44. 44 PPARβ/δ Agonists Modulate Platelet Function via a Mechanism Involving PPAR Receptors and Specific Association/Repression of PKCα–Brief Report [DOI]
45. 45 Peroxisome Proliferation-Activated Receptor δ Agonist GW0742 Interacts Weakly with Multiple Nuclear Receptors, Including the Vitamin D Receptor [DOI]
46. 46 Gambogic Acid Induces G0/G1 Cell Cycle Arrest and Cell Migration Inhibition Via Suppressing PDGF Receptor β Tyrosine Phosphorylation and Rac1 Activity in Rat Aortic Smooth Muscle Cells [DOI]
47. 47 Signal transduction involved in CTGF-induced production of chemokines in mesangial cells [DOI]
48. 48 Cardiac Peroxisome Proliferator-Activated Receptor δ (PPARδ) as a New Target for Increased Contractility without Altering Heart Rate [DOI]
49. 49 Differential sensitivities of the vascular KATP channel to various PPAR activators [DOI]
50. 50 Critical roles of PPARβ/δ in keratinocyte response to inflammation [DOI]
51. 51 The American Journal of Respiratory and Critical Care Medicine
52. 52 Arteriosclerosis, Thrombosis, and Vascular Biology [DOI]
53. 53 Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARα, β/δ, and γ [DOI]
54. 54 Attenuation of Colon Inflammation through Activators of the Retinoid X Receptor (Rxr)/Peroxisome Proliferator–Activated Receptor γ (Pparγ) Heterodimer [DOI]
55. 55 American Journal of Respiratory Cell and Molecular Biology [DOI]
56. 56 Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
57. 57 Peroxisome Proliferator-Activated Receptor (PPAR)β /δ: A New Potential Therapeutic Target for the Treatment of Metabolic Syndrome [DOI]

Cited by 6

Showing 5 of 6 known citations — external sources report more than can currently be individually listed.

Related research

• Evaluation of Anaesthetic Efficacy of Ocimum gratissimum on Clarias gariepinus Fingerlings during Transport — shares topic coverage
• Common Approaches of Cytochrome P450 (CYP) Induction Assays — shares topic coverage
• Optimization of Cultural and Nutritional Parameters for the Production of Laccase by Pleurotus ostreatus ARC280 — shares topic coverage
• In vitro Apical Shoot Culture and Callus Formation of Durian (Durio zibethinus Murray) — shares topic coverage
• Expression of Blood-Brain Barrier Antigens in Non-Brain Derived Endothelial Cells Despite Lack of Astrocyte Interactions — shares topic coverage